glipizide has been researched along with oligomycins in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, KE; During, MJ; Kerr, D; Leone, P; Sherwin, RS | 1 |
| Amoroso, S; Bernardi, H; De Weille, JR; Epelbaum, J; Fosset, M; Lazdunski, M; Mourre, C; Slama, A | 1 |
| Brioni, JD; Gopalakrishnan, M; Molinari, EJ; Monteggia, LM; Roch, JM; Scott, VE; Shieh, CC; Sullivan, JP; Whiteaker, KL | 1 |
3 other study(ies) available for glipizide and oligomycins
| Article | Year |
|---|---|
Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Deoxyglucose; gamma-Aminobutyric Acid; Glipizide; Glucose; Hypoglycemia; Insulin; Male; Microdialysis; Neurons; Oligomycins; Potassium Channels; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1995 |
ATP-modulated K+ channels sensitive to antidiabetic sulfonylureas are present in adenohypophysis and are involved in growth hormone release.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Affinity Labels; Animals; Calcium; Cells, Cultured; Diazoxide; Female; Glipizide; Glyburide; Growth Hormone; Hypoglycemic Agents; Kinetics; Membrane Potentials; Oligomycins; Pituitary Gland, Anterior; Potassium Channels; Rats; Receptors, Drug; Sulfonylurea Compounds | 1993 |
Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells.
Topics: ATP-Binding Cassette Transporters; Binding, Competitive; Cations; Cell Line; Deoxyglucose; Diazoxide; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Fluorescence; Gene Expression; Glipizide; Glyburide; Humans; Membrane Potentials; Oligomycins; Potassium Channels; Potassium Channels, Inwardly Rectifying; Radioligand Assay; Receptors, Drug; Recombinant Fusion Proteins; RNA, Messenger; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolazamide; Tolbutamide; Tritium | 2000 |